Shaping the paradigm in T2D treatment –
transitioning to injectable
therapy, real Life experience with Trulicity.
Prof. Michael Nauck
Head, Clinical Research, Division of Diabetology Medical Department I St. Josef-Hospital, Germany
Head, Clinical Research, Division of Diabetology Medical Department I St. Josef-Hospital, Germany
GLP-1RA- Systematic analysis: safety, tolerability and individualized approach
